View Single Post
  #1 (permalink)   Report Post  
Posted to alt.food.diabetic
RELIV-quality
 
Posts: n/a
Default Arthred® Studies Confirm - It Works :A European study of 356 patients with arthritis

no tabltets


Arthred®
Studies Confirm - It Works
Arthred, which is the centerpiece of the Relìv
Arthaffect formula, is already a very successful
and popular treatment for arthritis in Germany.
Its safety and effectiveness was proven through
$10 million in clinical trials. "Not only should
elderly people with joint aches take this product
but many young athletes who are experiencing
joint discomfort will also benefit," Dr. Pfeifer says.


A European study of 356 patients with arthritis
showed that almost all of the patients decreased
their use of joint medication, and the number
of joint injections needed per year significantly
decreased while taking Arthred. This study also
showed that patients got even better results the
longer they took the product.
In another study, researchers compared the response
of arthritis in three groups of joint-injured patients.
The first group received physical therapy alone.
The second group received both physical therapy
and the Arthred supplement. The third group used
Arthred alone. In the second and third groups,
which both included Arthred, 65 percent reported
symptom score improvements of "very good" or
"good." Thirty percent noted a "significant
improvement" and only 5 percent said "no
improvement at all."
"Most interesting was that the second and third
groups did equally well," Dr. Pfeifer says. "That
means the Arthred supplement was the chief reason
that all of these patients did so well. I don't know of
any drug that can achieve this kind of success rate."


A third study on Arthred showed significant
improvements in knee pain among young athletes
or young kids going through growth spurts.
Relìv Arthaffect - In Practice
Dr. Linda K. Bivins, a family practice physician
from Punta Gorda, FL, and member of the Relìv
Scientific Advisory Board, conducted an informal
study on Arthaffect in her office using 100
participants with a variety of conditions, including
osteoarthritis and rheumatoid arthritis of varying


send me an e-mail for more information: